Table 2.
eGFR | AF events/Total N | HR (95% CI), Model 1 | HR (95% CI), Model 2 |
---|---|---|---|
Continuous, baseline assessment | |||
eGFRcys, mL/min per 1.73 m2 | 780/9288 | 1.11 (1.06–1.17)* | 1.08 (1.03–1.14)* |
eGFRcreat, mL/min per 1.73 m2 | 780/9288 | 1.05 (0.99–1.11) | 1.04 (0.98–1.10) |
eGFRcreat‐cys, mL/min per 1.73 m2 | 780/9288 | 1.10 (1.04–1.16)* | 1.07 (1.01–1.14)* |
Continuous, repeated assessments † | |||
eGFRcreat, mL/min per 1.73 m2 | 780/9288 | 1.03 (0.97–1.09) | 1.02 (0.97–1.09) |
Categorical, baseline assessment | |||
Categories of eGFRcys | |||
eGFRcys ≥60 mL/min per 1.73 m2 | 545/7599 | Reference | Reference |
eGFRcys <60 mL/min per 1.73 m2 | 235/1689 | 1.45 (1.21–1.73)* | 1.37 (1.14–1.64)* |
Categories of eGFRcreat | |||
eGFRcreat ≥60 mL/min per 1.73 m2 | 657/8422 | Reference | Reference |
eGFRcreat <60 mL/min per 1.73 m2 | 123 / 866 | 1.27 (1.03–1.56)* | 1.22 (0.99–1.50) |
Categories of eGFRcreat‐cys | |||
eGFRcreat‐cys ≥60 mL/min per 1.73 m2 | 624/8186 | Reference | Reference |
eGFRcreat‐cys <60 mL/min per 1.73 m2 | 156/1102 | 1.35 (1.11–1.64)* | 1.27 (1.04–1.55) |
Model 1 is adjusted for age, sex and Rotterdam Study cohort. Model 2 is additionally adjusted for educational level, BMI, smoking, alcohol, serum cholesterol, diabetes, physical activity, and use of cardiac medication. HRs are given per 10 mL/min per 1.73 m2 decrease in eGFR. Cox proportional‐hazards models were used to investigate the associations between continuous/categorical eGFR at baseline and incident AF. Joint models were used to investigate the association between repeated assessments of eGFRcreat and incident AF. AF indicates atrial fibrillation; BMI, body mass index; eGFR, estimated glomerular filtration rate; eGFRcreat, eGFR based on serum creatinine; eGFRcreat‐cys, eGFR based on serum creatinine and serum cystatin C; eGFRcys, eGFR based on serum cystatin C; and HR, hazard ratio.
P<0.05.
Total of 55 917 repeated assessments of eGFR (median of 4 repeated assessments).